Literature DB >> 18842315

Quantitative risk assessment of human campylobacteriosis related to the consumption of chicken meat in two Italian regions.

Paolo Calistri1, Armando Giovannini.   

Abstract

Campylobacteriosis is the most frequently reported zoonotic disease in humans within the European Union. The consumption of contaminated chicken meat is considered one of the main sources of human infection. Although there are no official data on the incidence of Campylobacter infection in Italy, the available studies suggest that this infection is a major problem also in Italy. The authors developed a simulation model to quantitatively estimate the expected annual number of human cases of campylobacteriosis in the Italian regions of Abruzzo and Molise, due to the cross-contamination during the handling of Campylobacter jejuni contaminated chicken meat in domestic kitchen. The authors considered two different models for the dose-response relationship, given their crucial effects on the model's outputs. The expected percentage of human population, experiencing Campylobacter gastroenteritis episodes every year in Abruzzo e Molise regions, varied between 0.8% and 1.8%, according to the dose-response model.

Entities:  

Mesh:

Year:  2008        PMID: 18842315     DOI: 10.1016/j.ijfoodmicro.2008.08.021

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  2 in total

1.  Isolation, identification and differentiation of Campylobacter spp. using multiplex PCR assay from goats in Khartoum State, Sudan.

Authors:  Atif Elbrissi; Y A Sabeil; Khalda A Khalifa; Khalid Enan; Osama M Khair; A M El Hussein
Journal:  Trop Anim Health Prod       Date:  2017-02-04       Impact factor: 1.559

2.  Tracing Back Clinical Campylobacter jejuni in the Northwest of Italy and Assessing Their Potential Source.

Authors:  Elisabetta Di Giannatale; Giuliano Garofolo; Alessandra Alessiani; Guido Di Donato; Luca Candeloro; Walter Vencia; Lucia Decastelli; Francesca Marotta
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.